2010
DOI: 10.1186/1475-2859-9-65
|View full text |Cite
|
Sign up to set email alerts
|

Antibiotic-free selection in E. coli: new considerations for optimal design and improved production

Abstract: BackgroundThe increasing regulatory requirements to which biological agents are subjected will have a great impact in the field of industrial protein expression and production. There is an expectation that in a near future, there may be "zero tolerance" towards antibiotic-based selection and production systems. Besides the antibiotic itself, the antibiotic resistance gene is an important consideration. The complete absence of antibiotic-resistance gene being the only way to ensure that there is no propagation … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
43
0
1

Year Published

2012
2012
2021
2021

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(45 citation statements)
references
References 19 publications
1
43
0
1
Order By: Relevance
“…This ineffectiveness of ampicillin, in addition to the deprecation by regulatory authorities of its use in biotherapeutics and biomaterials production due to safety concerns232425, prompted us to investigate other plasmid stabilisation systems. Indeed, use of β-lactam antibiotics such as ampicillin poses safety risks associated with their potential for causing serious hypersensitivity reactions in patients and for leading to the spread of antibiotic resistance traits to the environments2526.…”
mentioning
confidence: 99%
“…This ineffectiveness of ampicillin, in addition to the deprecation by regulatory authorities of its use in biotherapeutics and biomaterials production due to safety concerns232425, prompted us to investigate other plasmid stabilisation systems. Indeed, use of β-lactam antibiotics such as ampicillin poses safety risks associated with their potential for causing serious hypersensitivity reactions in patients and for leading to the spread of antibiotic resistance traits to the environments2526.…”
mentioning
confidence: 99%
“…The gene encoding lysis protein E (see Table S1 in the supplemental material) from bacteriophage X174 (obtained from GenBank [NC_001422.1] and synthesized by GeneArt) was, using EcoRI and BamHI, cloned into the rhamnose promoter-based expression vector pLarge (pUC origin, Km r ), which is derived from pRha67 (26), yielding pRL1, and into the tetracycline promoter (tetA)-based expression vector pASK_IBA 3 (pUC origin, Amp r ), yielding pTL1 (27). To be able to clone the gene encoding lysis protein E directly from pRL1 into pASK_IBA 3 , its multiple cloning site was modified by amplifying the entire plasmid and introducing EcoRI and BamHI restriction sites using the Roche Expand long template PCR system (for primer sequences, see Table S1 in the supplemental material) (28). The pHbpD(p15a)-ESAT6 vector (p15A ori, Cm r ) was constructed by substituting the pMB1 origin of replication of pHbpD(⌬d1)-ESAT6 (19) by the PCR-amplified p15A origin of replication of pBAD33 using the EcoRI and SalI restriction sites (for primer sequences, see Table S1 in the supplemental material).…”
Section: Methodsmentioning
confidence: 99%
“…A principal motivação está no fato de este ser um organismo bem caracterizado do ponto de vista genético, fisiológico e de expressão (Choi et al, 2006). Apesar de todas as conhecidas vantagens do uso da E. coli como hospedeiro, a instabilidade plasmidial é uma preocupação significativa para a utilização industrial destes OGMs, uma vez que estas construções utilizam vetores bacterianos que contém um gene de resistência a antibiótico como marcador seletivo (Spirer et al, 2005;Peubez et al, 2010). Os antibióticos (ou seus produtos oriundos da degradação) podem contaminar a biomassa ou produto, tornando-se necessária a sua remoção do produto final e efluente (Spirer et al, 2005).…”
Section: Introductionunclassified